Acyclovir Treatment of the Chronic Fatigue Syndrome
- 29 December 1988
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 319 (26), 1692-1698
- https://doi.org/10.1056/nejm198812293192602
Abstract
Twenty-seven adults with a diagnosis of the chronic fatigue syndrome were enrolled in a double-blind, placebo-controlled study of acyclovir therapy. The patients had had debilitating fatigue for an average of 6.8 years, accompanied by persisting antibodies to Epstein–Barr virus early antigens (titers ≥1:40) or undetectable levels of antibodies to Epstein–Barr virus nuclear antigens (titers <1:2) or both. Each course of treatment consisted of intravenous placebo or acyclovir (500 mg per square meter of body-surface area) administered every eight hours for seven days. The same drug was then given orally for 30 days (acyclovir, 800 mg four times daily). There were six-week observation periods before, between, and after the treatments.This publication has 35 references indexed in Scilit:
- Allergy and the chronic fatigue syndromeJournal of Allergy and Clinical Immunology, 1988
- Depression in Patients with Neuromyasthenia (Benign Myalgic Encephalomyelitis)The International Journal of Psychiatry in Medicine, 1988
- The Chronic Mononucleosis SyndromeThe Journal of Infectious Diseases, 1988
- Selective Lack of Antibody to a Component of EB Nuclear Antigen in Patients with Chronic Active Epstein-Barr Virus InfectionThe Journal of Infectious Diseases, 1987
- Effect of Acyclovir on Infectious Mononucleosis: A Double-Blind, Placebo-Controlled StudyThe Journal of Infectious Diseases, 1986
- Chronic Mononucleosis SyndromeSouthern Medical Journal, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- Immunological reason for chronic ill health after infectious mononucleosis.BMJ, 1983
- Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte InterferonScience, 1982
- EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.Journal of Clinical Pathology, 1979